NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 153 filers reported holding NOVAVAX INC in Q4 2014. The put-call ratio across all filers is 6.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $4,856,000 | +85.3% | 667,922 | +31.5% | 1.22% | +85.4% |
| Q1 2016 | $2,621,000 | -35.6% | 507,922 | +4.7% | 0.66% | -32.8% |
| Q4 2015 | $4,072,000 | +17.9% | 485,310 | -0.7% | 0.98% | +0.1% |
| Q3 2015 | $3,455,000 | -20.6% | 488,666 | +25.2% | 0.98% | -19.3% |
| Q2 2015 | $4,349,000 | -31.6% | 390,326 | -49.2% | 1.21% | -27.4% |
| Q1 2015 | $6,357,000 | +7.7% | 768,702 | -22.8% | 1.67% | +9.6% |
| Q4 2014 | $5,903,000 | +27.7% | 995,427 | -10.2% | 1.52% | +10.2% |
| Q3 2014 | $4,622,000 | +1.2% | 1,108,377 | +12.2% | 1.38% | +9.1% |
| Q2 2014 | $4,565,000 | +39.9% | 988,000 | +37.2% | 1.27% | +34.7% |
| Q1 2014 | $3,262,000 | -0.4% | 720,000 | -30.8% | 0.94% | -8.1% |
| Q3 2013 | $3,276,000 | – | 1,040,000 | – | 1.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 8,330,000 | $10,496,000 | 0.39% |
| Alden Global Capital LLC | 640,500 | $807,000 | 0.28% |
| Quantitative Investment Management, LLC | 3,784,100 | $4,767,000 | 0.12% |
| Eventide Asset Management | 1,449,700 | $1,827,000 | 0.12% |
| Bellevue Group AG | 325,000 | $410,000 | 0.08% |
| Virtus ETF Advisers LLC | 196,162 | $247,000 | 0.07% |
| Rock Springs Capital Management LP | 820,000 | $1,033,000 | 0.07% |
| Quantbot Technologies LP | 462,250 | $582,000 | 0.06% |
| Traynor Capital Management, Inc. | 43,361 | $55,000 | 0.04% |
| Tekla Capital Management LLC | 571,000 | $719,000 | 0.03% |